Atlas FDA

INTERSTIM THERAPY SYSTEM FOR BOWEL

FDA premarket approval P080025/S111 · decided 2016-07-07

Approval details

PMA number
P080025
Supplement
S111
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INTERSTIM THERAPY SYSTEM FOR BOWEL
Generic name
Implanted electrical device intended for treatment of fecal incontinence
Applicant
Medtronic Neuromodulation
Date received
2016-06-09
Decision date
2016-07-07
Days to decision
28 days
Decision code
OK30
Product code
QON
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
Addition of new peel test and pouch seal equipment used in the Pouch Sealing process and Blister Package and Pouch Peel Testing process and introduction of a new peel test operation procedure at the Medtronic Sullivan Lake facility.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23